RPRX
Royalty Pharma plc · Healthcare
EVP, Research, Investments Marshall Urist sold $790K of Royalty Pharma plc
Sold$790,346
$39.52Price
20,000Shares
−23%Stake
What RPRX did after the filing
- The stock from Wed, Jan 21 open, $38.82
- +17.2%
- S&P 500, same days
- +0.2%
Measured over 30 trading days, to the Mar 5 close.
Traded Fri, Jan 16. Filed Tue, Jan 20, 5:00 PM ET, after the close. Returns use the Jan 21 open and the Mar 5 close. Not investment advice.